McKinney, TX – Rebecca E. Zorn, serving as Executive Vice President and Chief Talent Officer at GLOBE LIFE INC. (NASDAQ:GL), has executed a transaction involving the sale of 2,000 shares of the company's common stock. The sale, reported on June 18, 2026, according to a filing with the Securities and Exchange Commission, resulted in a total sale value of $340,193.
The shares were sold at prices ranging from $169.70 to $170.41 per share, with an average reported price of $170.0967. This transaction occurs as Globe Life stock trades near its 52-week high of $172.74, with shares delivering a strong 43% return over the past year. The stock currently trades at a P/E ratio of 12.1 with a market capitalization of $13.6 billion.
Prior to the sale, Ms. Zorn acquired an equal number of shares, 2,000, through the exercise of employee stock options. These shares were acquired at a price of $98.32 each, totaling $196,640. The options had an exercise date of February 24, 2024, and are set to expire on February 24, 2028.
Following these transactions, Ms. Zorn directly holds 17,797.0997 shares of GLOBE LIFE INC. common stock. She also retains 14,200 employee stock options. The Form 4 report detailing these changes in beneficial ownership was filed on June 22, 2026.
In other recent news, Globe Life Inc. reported its first-quarter 2026 earnings, showing a slight miss in earnings per share (EPS) compared to forecasts. The company posted an EPS of $3.43, just below the expected $3.48, representing a 1.44% negative surprise. Revenue aligned with projections, coming in at $1.56 billion. Truist Securities raised its price target for Globe Life shares to $185 from $180, citing an increased earnings per share estimate for 2026 to $15.60 from $15.30. Raymond James also increased its price target to $208 from $188, maintaining a Strong Buy rating due to the company’s strong cash flow generation. BMO Capital adjusted its price target to $150 from $148, maintaining a Market Perform rating, and noted a 4% increase in the midpoint of Globe Life’s excess cash flow guidance. These developments reflect Globe Life’s ongoing financial strategies and market performance.